U-Screen Dx

U-Screen Dx is an early stage biotechnology company focusing on developing innovative cancer screening tests to provide cancer genetics for early detection of cancer in order to improve cancer patient care and ultimately save lives. The company’s goal is to provide a sensitive and noninvasive DNA test for cancer screening based on our patented cancer-targeted next generation sequencing (NGS) technology platform; in order to accurately and simultaneously detect both genetic and epigenetic circulating DNA markers in urine and blood for all cancers that have known DNA modifications.